Vitamin C deficiency in dialysis patients - Are we perceiving the tip of an iceberg?

Nephrology Dialysis Transplantation

Volumn 22, Issue 2, 2007, Pages 328-331

  Handelman, Garry J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Anemia; Haemodialysis; Iron; Oxalosis; Vitamin C

Indexed keywords

ASCORBIC ACID; ERYTHROPOIETIN;

ANEMIA; ARTICLE; ASCORBIC ACID DEFICIENCY; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; ERYTHROPOIESIS; HEMODIALYSIS PATIENT; HUMAN; IRON ABSORPTION; IRON METABOLISM; KIDNEY CLEARANCE; OXALOSIS; PRIORITY JOURNAL; SCURVY; SIDEROSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; DIETARY SUPPLEMENTS; ERYTHROPOIESIS; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL REPLACEMENT THERAPY; VITAMINS;

EID: 33846684021     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl534     Document Type: Article

References (44)

1. Sullivan JF, Eisenstein AB. Ascorbic acid depletion during hemodialysis. JAMA 1972; 220: 1697-1699
2. Ahmed J, Weisberg LS. Hyperkalemia in dialysis patients. Semin Dial 2001; 14: 348-356
3. Durose CL, Holdsworth M, Watson V et al. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. J Am Diet Assoc 2004; 104: 35-41
4. Morena M, Cristol JP, Bosc JY et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: A contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 422-427
5. Bohm V, Tiroke K, Schneider S et al. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Viram Nutr Res 1997; 67: 262-266
6. Jackson P, Loughrey CM, Lightbody JH et al. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-1138
7. Levine M, Rumsey SC, Daruwala R et al. Criteria and recommendations for vitamin C intake. JAMA 1999; 281: 1415-1423
8. Levine M, Runsey S, Wang Y et al. Vitamin C. In: Ziegler EE, Filer LJ,Jr, eds. Present Knowledge in Nutrition. ILSI Press, Washington, DC: 1996; 146-159
9. Rolton HA, McConnell KM, Modi KS et al. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis. Nephrol Dial Transplant 1991; 6: 440-443
10. Derman D, Sayers M, Lynch SR et al. Iron absorption from a cereal-based meal containing cane sugar fortified with ascorbic acid. Br J Nutr 1977; 38: 261-269
11. Fidler MC, Davidsson L, Zeder C et al. Iron absorption from ferrous fumarate in adult women is influenced by ascorbic acid but not by Na2EDTA. Br J Nutr 2003; 90: 1081-1085
12. Nissenson AR, Lindsay RM, Swan S et al. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial. Am J Kidney Dis 1999; 33: 471-482
13. Charytan C, Qunibi W, Bailie GR. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract 2005; 100: C55-c62
14. Sikole A, Stojanovic A, Polenakovic M et al. How erythropoietin affects bone marrow of uremic patients. Am J Nephrol 1997; 17: 128-136
15. Lipschitz DA, Bothwell TH, Seftel HC et al. The role of ascorbic acid in the metabolism of storage iron. Br J Haematol 1971; 20: 155-163
16. Wapnick AA, Bothwell TH, Seftel H. The relationship between serum iron levels and ascorbic acid stores in siderotic Bantu. Br J Haematol 1970; 19: 271-276
17. Lynch SR, Seftel HC, Torrance JD et al. Accelerated oxidative catabolism of ascorbic acid in siderotic Bantu. Am J Clin Nutr 1967; 20: 641-647
18. Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci 1993; 38: 257-268
19. Charytan C, Levin N, Al-Saloum M et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American Clinical Trial. Am J Kidney Dis 2001; 37: 300-307.
20. Mircescu G, Garneata L, Capusa C et al. Intravenous iron supplementation for the treatment of anaemia. in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant 2006; 21: 120-124
21. Fleming LW, Hopwood D, Shepherd AN et al. Hepatic iron in dialysed patients given intravenous iron dextran. J Clin Pathol 1990; 43: 119-124
22. Van Wyck D, Anderson J, Johnson K. Labile iron in parenteral iron formulations: A quantitative and comparative study. Nephrol Dial Transplant 2004; 19: 561-565
23. Danielson BG, Salmonson T, Derendorf H et al. Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittelforschung 1996; 46: 615-621
24. Seligman PA, Dahl NV, Strobos J et al. Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects. Pharmacotherapy 2004; 24: 574-583
25. Henderson P, Hillman R. Characteristics of iron dextran utilization in man. Blood 1969; 34: 357-375
26. Overly CC, Lee KD, Berthiaume E et al. Quantitative measurement of intraorganelle pH in the endosomal-lysosomal pathway in neurons by using ratiometric imaging with pyranine. Proc Natl Acad Sci USA 1995; 92: 3156-3160
27. Gastaldello K, Vereerstraeten A, Nzame-Nze T et al. Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant 1995; 10: 44-47
28. Tarng DC, Wei YH, Huang TP et al. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 1999; 55: 2477-2486
29. Attallah N, Osman-Malik Y, Frinak S et al. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis 2006; 47: 644-654
30. Chan D, Irish A, Dogra G. Efficacy and safety of oral versus intravenous ascorbic acid for anaemia in haemodialysis patients. Nephrology 2005; 10: 336-340
31. Deicher R, Ziai F, Habicht A et al. Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant 2004; 19: 2319-2324
32. Rahmati MA, Craig RG, Homel P et al. Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis 2002; 40: 983-989
33. Levine M, Conry-Cantilena C, Wang Y et al. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996; 93: 3704-3709
34. Khajehdehi P, Mojerlou M, Behzadi S et al. A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant 2001; 16: 1448-1451
35. Fain O. Musculoskeletal manifestations of scurvy. Joint Bone Spine 2005; 72: 124-128
36. Salyer WR, Keren D. Oxalosis as a complication of chronic renal failure. Kidney Int 1973; 4: 61-66
37. Friedman AH, Charles NC. Retinal oxalosis in two diabetic patients. Am J Ophthalmol 1974; 78: 189-195
38. Wells CG, Johnson RJ, Qingli L et al. Retinal oxalosis. A clinicopathologic report. Arch Ophthahnol 1989; 107: 1638-1643
39. Tomson CR, Channon SM, Ward MK et al. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis. Nephrol Dial Transplant 1989; 4: 792-799
40. Canavese C, Petrarulo M, Massarenti P et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005; 45: 540-549
41. Deicher R, Ziai F, Bieglmayer C et al. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1811-1818
42. Andreucci VE, Fissell RB, Bragg-Gresham JL et al. Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients. Am J Kidney Dis 2004; 44: 61-67
43. Ching SY, Prins AW, Beilby JP. Stability of ascorbic acid in serum and plasma prior to analysis. Ann Clin Biochem 2002; 39: 518-520
44. Chung WY, Chung JK, Szeto YT et al. Plasma ascorbic acid: Measurement, stability and clinical utility revisited. Clin Biochem 2001; 34: 623-627